Literature DB >> 31197689

Insurance Coverage Type Impacts Hospitalization Patterns Among Patients with Hepatopancreatic Malignancies.

Rittal Mehta1, Kota Sahara1, Katiuscha Merath1, J Madison Hyer1, Diamantis I Tsilimigras1, Anghela Z Paredes1, Aslam Ejaz1, Jordan M Cloyd1, Mary Dillhoff1, Allan Tsung1, Timothy M Pawlik2.   

Abstract

INTRODUCTION: Disparities in health and healthcare access remain a major problem in the USA. The current study sought to investigate the relationship between patient insurance status and hospital selection for surgical care.
METHODS: Patients who underwent liver or pancreatic resection for cancer between 2004 and 2014 were identified in the National Inpatient Sample. The association of insurance status and hospital type was examined.
RESULTS: In total, 22,254 patients were included in the study. Compared with patients with private insurance, Medicaid patients were less likely to undergo surgery at urban non-teaching hospitals (OR = 0.36, 95%CI 0.22-0.59) and urban teaching hospitals (OR = 0.54, 95%CI 0.34-0.84) than rural hospitals. Medicaid patients were less likely to undergo surgery at private investor-owned hospitals (OR = 0.53, 95%CI 0.38-0.73) than private non-profit hospitals. In contrast, uninsured patients were 2.2-fold more likely to go to government-funded hospitals rather than private non-profit hospitals (OR = 2.19, 95%CI 1.76-2.71).
CONCLUSION: Insurance status was strongly associated with the type of hospital in which patients underwent surgery for liver and pancreatic cancers. Addressing the reasons for inequitable access to different hospital settings relative to insurance status is essential to ensure that all patients undergoing pancreatic or liver surgery receive high-quality surgical care.

Entities:  

Keywords:  Hepatopancreatic cancer; Hospital utilization; Insurance; Medicaid

Mesh:

Year:  2019        PMID: 31197689      PMCID: PMC7011949          DOI: 10.1007/s11605-019-04288-9

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  47 in total

1.  Risk of morbidity and mortality following hepato-pancreato-biliary surgery.

Authors:  Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2012-07-04       Impact factor: 3.452

2.  CDC Health Disparities and Inequalities Report - United States, 2013. Foreword.

Authors:  Thomas R Frieden
Journal:  MMWR Suppl       Date:  2013-11-22

3.  Variation in the cost-of-rescue among medicare patients with complications following hepatopancreatic surgery.

Authors:  Katiuscha Merath; Qinyu Chen; Fabio Bagante; Steven Sun; Ozgur Akgul; Jay J Idrees; Mary Dillhoff; Carl Schmidt; Jordan Cloyd; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2018-09-25       Impact factor: 3.647

4.  The Impact of Discharge Timing on Readmission Following Hepatopancreatobiliary Surgery: a Nationwide Readmission Database Analysis.

Authors:  Katiuscha Merath; Fabio Bagante; Qinyu Chen; Eliza W Beal; Ozgur Akgul; Jay Idrees; Mary Dillhoff; Jordan Cloyd; Carl Schmidt; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

5.  Hot spotting surgical patients undergoing hepatopancreatic procedures.

Authors:  Katiuscha Merath; Qinyu Chen; Morgan Johnson; Rittal Mehta; Eliza W Beal; Mary Dillhoff; Jordan Cloyd; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2018-11-27       Impact factor: 3.647

6.  Predictors of surgical intervention for hepatocellular carcinoma: race, socioeconomic status, and hospital type.

Authors:  Yulia Zak; Kim F Rhoads; Brendan C Visser
Journal:  Arch Surg       Date:  2011-03-21

7.  Effects of health insurance and race on colorectal cancer treatments and outcomes.

Authors:  R G Roetzheim; N Pal; E C Gonzalez; J M Ferrante; D J Van Durme; J P Krischer
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

8.  Association of Income Disparities with Patient-Reported Healthcare Experience.

Authors:  Victor Okunrintemi; Rohan Khera; Erica S Spatz; Joseph A Salami; Javier Valero-Elizondo; Haider J Warraich; Salim S Virani; Ron Blankstein; Michael J Blaha; Timothy M Pawlik; Kumar Dharmarajan; Harlan M Krumholz; Khurram Nasir
Journal:  J Gen Intern Med       Date:  2019-02-19       Impact factor: 5.128

9.  The impact of health insurance status on stage at diagnosis of oropharyngeal cancer.

Authors:  Amy Y Chen; Nicole M Schrag; Michael T Halpern; Elizabeth M Ward
Journal:  Cancer       Date:  2007-07-15       Impact factor: 6.860

10.  Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis?

Authors:  Amy Y Chen; Nicole M Schrag; Michael Halpern; Andrew Stewart; Elizabeth M Ward
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.